Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

1 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Screening

- 26/09/17 - 1 modulo, 15 itemgroups, 61 elementi, 1 linguaggio
Itemgroups: General Information, Informed Consent, Demography, Vital signs, Date of onset of symptoms of parkinson´s disease, Modified Hoehn and Yahr Parkinsons Disease Staging, Significant medical / surgical history and physical examination, Details on Significant medical or surgical condition, Prior anti-parkinson medication, Details on prior anti-parkinson medication, Other prior medication (excluding anti-parkinson medication), Details on other prior medication (excluding anti-parkinson medication), Inclusion Criteria, Exclusion Criteria, Laboratory tests
Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial